Immune Checkpoint Inhibitor Therapy

Immune Checkpoint Inhibitor Therapy

Immune checkpoint inhibitor therapy in India for selected cancers using PD-1, PD-L1 or CTLA-4-directed immunotherapy after biomarker and specialist oncology review.

✓Our healthcare experts will be by your side, helping you make the best treatment choice.

Our services are FREE and by using our services your hospital bill does not increase!

About Immune Checkpoint Inhibitor Therapy

Immune checkpoint inhibitor therapy in India uses immunotherapy medicines that release inhibitory signals on immune cells so they can attack selected cancers more effectively. Drugs targeting pathways such as PD-1, PD-L1 and CTLA-4 are used only for cancer types and clinical situations where evidence supports benefit, either alone or in combination with chemotherapy, targeted therapy or other immunotherapy.

Treatment selection depends on cancer type, stage, previous therapy and relevant biomarkers, which may include PD-L1 expression, microsatellite instability or mismatch-repair status, tumour mutational burden or other tumour-specific markers. The oncology team also reviews autoimmune disease, transplant history, organ function and previous immune-related toxicity before treatment.

Checkpoint inhibitors can cause immune-related adverse events affecting the skin, bowel, liver, lungs, thyroid, pituitary and other organs. New shortness of breath, severe diarrhoea, jaundice, confusion, severe headache or profound weakness can require urgent assessment because some toxicities progress quickly.

Cost in India depends on the specific drug, dose and body weight where relevant, treatment frequency, number of cycles, biomarker testing, infusion charges, imaging and management of adverse effects. Major tertiary cancer hospitals in India provide medical oncologists, molecular pathology, infusion centres, imaging and multidisciplinary toxicity management. Medical Help India can connect international patients with a suitable healthcare partner to review pathology and biomarkers, assess whether immunotherapy is indicated and obtain an individual treatment estimate.

What's Included

Pre-treatment consultation
Diagnostic tests & evaluation
Treatment procedure
Post-treatment care
Hospital stay (if required)
Follow-up consultations

Why consider treatment in India?

Access to experienced specialists

Advanced treatment and diagnostic options

More affordable hospital care

Shorter waiting times for treatment

Help comparing hospitals, plans and costs

Support with appointments, travel and follow-up

Cost in India

USD
$1,200–3,000

Final costs depend on the medical assessment, hospital, room category and clinical needs.

Get a Cost Estimate

How it works

1

Share your details

Tell us about your health concerns, age and current location.

2

Receive a call

We call you to discuss your situation, needs and questions.

3

Receive a treatment plan

Get information about the most suitable treatment plan, hospital and estimated cost.

4

Choose your plan

Review the options and agree on your care and travel plan.

5

Get full support

Receive full support throughout every stage of your care journey.

6

Receive care in India

Receive your planned care with support throughout your stay.

Top Hospitals for Immune Checkpoint Inhibitor Therapy

View All Hospitals →

Top Doctors for Immune Checkpoint Inhibitor Therapy

View All Doctors →

Frequently Asked Questions

How much does Immune Checkpoint Inhibitor Therapy cost in India?

The cost of Immune Checkpoint Inhibitor Therapy in India depends on the hospital, specialist team, investigations, treatment complexity and any additional care required. A final estimate is usually prepared after a healthcare provider reviews your medical records.

Which medical reports are useful to have ready for Immune Checkpoint Inhibitor Therapy?

Have ready: the most recent records you have, such as your diagnosis, doctor’s notes, blood tests, imaging, pathology reports, procedure reports and current medication list. The exact documents needed depend on the treatment and your medical history.

Which cancers can be treated with checkpoint inhibitors?

Use depends on cancer type, stage, treatment setting and sometimes biomarkers; they are not appropriate for every cancer.

What are immune-related adverse events?

Checkpoint inhibitors can cause the immune system to inflame normal organs, including the bowel, lungs, liver, skin and endocrine glands.

Are biomarkers always required?

Not always. PD-L1, MSI/MMR and other biomarkers are important in some cancers, while other indications are based on different clinical criteria.

Doctor discussing treatment options with a patient

Our services are FREE

We connect you with leading hospitals and specialists in India. You pay the hospital directly.

TelegramWhatsApp